Livforsakringsbolaget Skandia Omsesidigt Purchases 308 Shares of CME Group Inc. (NASDAQ:CME)

Livforsakringsbolaget Skandia Omsesidigt lifted its position in CME Group Inc. (NASDAQ:CMEFree Report) by 67.1% during the 4th quarter, HoldingsChannel reports. The firm owned 767 shares of the financial services provider’s stock after acquiring an additional 308 shares during the quarter. Livforsakringsbolaget Skandia Omsesidigt’s holdings in CME Group were worth $165,000 at the end of the most recent reporting period.

Several other large investors have also recently made changes to their positions in the company. OFI Invest Asset Management bought a new stake in CME Group during the third quarter worth approximately $25,000. MayTech Global Investments LLC bought a new stake in CME Group during the fourth quarter worth approximately $25,000. Power Corp of Canada bought a new stake in CME Group during the first quarter worth approximately $26,000. Providence Capital Advisors LLC bought a new stake in CME Group during the first quarter worth approximately $30,000. Finally, Harbor Investment Advisory LLC increased its stake in CME Group by 966.7% during the fourth quarter. Harbor Investment Advisory LLC now owns 160 shares of the financial services provider’s stock worth $34,000 after acquiring an additional 145 shares during the last quarter. 87.75% of the stock is owned by institutional investors.

CME Group Stock Up 0.6 %

Shares of NASDAQ CME opened at $209.65 on Friday. The company has a debt-to-equity ratio of 0.13, a quick ratio of 1.02 and a current ratio of 1.02. The firm has a market capitalization of $75.47 billion, a price-to-earnings ratio of 23.64, a PEG ratio of 5.92 and a beta of 0.49. The stock has a 50 day moving average price of $214.26 and a 200 day moving average price of $211.61. CME Group Inc. has a 52-week low of $175.73 and a 52-week high of $223.80.

CME Group (NASDAQ:CMEGet Free Report) last announced its quarterly earnings results on Wednesday, February 14th. The financial services provider reported $2.37 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.27 by $0.10. The firm had revenue of $1.44 billion during the quarter, compared to analyst estimates of $1.43 billion. CME Group had a return on equity of 12.32% and a net margin of 57.83%. CME Group’s quarterly revenue was up 19.2% on a year-over-year basis. During the same quarter in the previous year, the business earned $1.92 earnings per share. Sell-side analysts expect that CME Group Inc. will post 9.56 earnings per share for the current year.

CME Group Increases Dividend

The business also recently announced a quarterly dividend, which was paid on Tuesday, March 26th. Shareholders of record on Friday, March 8th were issued a dividend of $1.15 per share. The ex-dividend date of this dividend was Thursday, March 7th. This represents a $4.60 dividend on an annualized basis and a yield of 2.19%. This is a positive change from CME Group’s previous quarterly dividend of $1.10. CME Group’s dividend payout ratio is currently 51.86%.

Analysts Set New Price Targets

Several brokerages have weighed in on CME. Deutsche Bank Aktiengesellschaft reissued a “hold” rating and set a $210.00 price objective (down from $235.00) on shares of CME Group in a research note on Friday, April 5th. Barclays boosted their price objective on CME Group from $225.00 to $226.00 and gave the stock an “equal weight” rating in a research note on Monday, April 8th. The Goldman Sachs Group lowered CME Group from a “neutral” rating to a “sell” rating and set a $195.00 target price for the company. in a research report on Wednesday, January 3rd. Morgan Stanley boosted their target price on CME Group from $222.00 to $225.00 and gave the company an “equal weight” rating in a research report on Tuesday, April 9th. Finally, Keefe, Bruyette & Woods restated a “market perform” rating and set a $229.00 target price on shares of CME Group in a research report on Wednesday, April 3rd. Two equities research analysts have rated the stock with a sell rating, seven have issued a hold rating and two have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock has an average rating of “Hold” and an average target price of $215.70.

Read Our Latest Analysis on CME

CME Group Company Profile

(Free Report)

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

Featured Stories

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CMEFree Report).

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.